Close Menu

NEW YORK – OraSure Technologies reported after the close of the market on Wednesday that its third quarter revenues fell 22 percent year over year as overall product revenues declined 19 percent.

The firm also announced it will acquire Diversigen, a Houston-based microbiome and metagenomics consulting, sequencing, and data analysis service provider, for a cash purchase price of $12.0 million and the potential for an additional earn-out payment tied to revenue performance.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.

According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.

New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.

In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.